Abstract | BACKGROUND: The effects of selective alpha-agonist medetomidine and alpha 2-antagonist atipamezole on gastrointestinal motility were studied. METHODS: The passage of intragastrically administered Evans blue in the small bowel of unanesthetized rats was followed, and the stomachs were weighted after killing the rats. RESULTS: Subcutaneous medetomidine, 0.01-0.1 mg/kg, was found to delay small intestinal transit but not gastric emptying, with a maximal effect seen at 0.03 mg/kg. Atipamezole fully reversed the effect of 0.1 mg/kg of medetomidine with a dose of 2.5 mg/kg. Atipamezole alone did not affect small intestinal transit. Subcutaneous morphine, 6 mg/kg, delayed gastric emptying and small intestinal transit, whereas intraperitoneal morphine only delayed gastric emptying. Subcutaneous atipamezole, 0.06 mg/kg, was partially able to reverse the delayed intestinal transit but did not inhibit morphine-induced gastric retention. Subcutaneous atipamezole, 0.06 mg/kg, reversed laparotomy-induced ileus completely. CONCLUSIONS:
|
Authors | H Tanila, T Kauppila, T Taira |
Journal | Gastroenterology
(Gastroenterology)
Vol. 104
Issue 3
Pg. 819-24
(Mar 1993)
ISSN: 0016-5085 [Print] United States |
PMID | 8095034
(Publication Type: Journal Article)
|
Chemical References |
- Adrenergic alpha-Agonists
- Adrenergic alpha-Antagonists
- Imidazoles
- Receptors, Adrenergic, alpha
- atipamezole
- Morphine
- Medetomidine
|
Topics |
- Adrenergic alpha-Agonists
(pharmacology)
- Adrenergic alpha-Antagonists
(pharmacology)
- Analysis of Variance
- Animals
- Dose-Response Relationship, Drug
- Gastric Emptying
(drug effects)
- Gastrointestinal Motility
(drug effects)
- Imidazoles
(pharmacology, therapeutic use)
- Intestinal Obstruction
(drug therapy, etiology)
- Laparotomy
(adverse effects)
- Male
- Medetomidine
- Morphine
(pharmacology)
- Rats
- Rats, Wistar
- Receptors, Adrenergic, alpha
(drug effects, physiology)
|